Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.45 |
| ▸ | MAOB | P27338 | 5/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29395934 | 1.00 | MAOA (0.45) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL24510001 | 0.97 | MAOA (0.43) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL1501421 | 0.95 | MAOA (0.49) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL22394445 | 0.95 | MAOA (0.42) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL22215240 | 0.94 | MEN1 (0.43) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL22180791 | 0.94 | MAOB (0.41) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL24949032 | 0.94 | ESR1 (0.42) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL15695721 | 0.93 | MAOA (0.43) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL17298634 | 0.92 | MAOA (0.39) | MAOAMAOBTDP1MAPTL3MBTL1 | |
| SCHEMBL17282278 | 0.92 | MAOA (0.60) | MAOAMAOBTDP1MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1705 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070022-A1 | DESALINATION SYSTEM WITH POLYIMIDE MEMBRANE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-03-12 | — | — | US | claimed |
| US-12486369-B2 | Polyimide-based film having excellent surface evenness and method for producing same | KOLON INDUSTRIES, INC. (KR) | 2025-12-02 | — | — | US | claimed |
| EP-4036159-B1 | POLYIMIDE-BASED FILM HAVING EXCELLENT SURFACE EVENNESS AND METHOD FOR PRODUCING SAME | KOLON INC (KR) | 2025-08-06 | — | — | EP | claimed |
| US-20250197583-A1 | THERMALLY TREATED POLYAMIC AMIDE AEROGEL | Blueshift Materials, Inc. (US) | 2025-06-19 | — | — | US | claimed |
| EP-4564066-A1 | OPTICAL FILM AND DISPLAY DEVICE COMPRISING SAME | Kolon Industries, Inc. (KR) | 2025-06-04 | — | — | EP | claimed |
| EP-3408318-B1 | POLYMER AEROGEL WITH IMPROVED MECHANICAL AND THERMAL PROPERTIES | BLUESHIFT MAT INC (US) | 2025-04-16 | — | — | EP | claimed |
| US-20250109251-A1 | OPTICAL FILM AND METHOD OF PREPARING SAME | KOLON INDUSTRIES, INC. (KR) | 2025-04-03 | — | — | US | claimed |
| US-20250109270-A1 | THERMALLY TREATED POLYAMIC AMIDE AEROGEL | Blueshift Materials, Inc. | 2025-04-03 | — | — | US | claimed |
| US-20240390860-A1 | POLYIMIDE-BASED MEMBRANES FOR DESALINATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-11-28 | — | — | US | claimed |
| US-12152122-B2 | Thermally treated polyamic amide aerogel | Blueshift Materials, Inc. (US) | 2024-11-26 | — | — | US | claimed |
| EP-1672009-A1 | Thermally conductive polyimide film composites having high thermal conductivity useful in an electronic device | E.I.Du pont de nemours and company (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1672008-A1 | Thermally conductive polyimide film composites having high mechanical elongation useful as a heat conducting portion of an electronic device | E.I.Du pont de nemours and company (US) | 2006-06-21 | — | — | EP | claimed |
| US-20060124693-A1 | Thermally conductive polyimide film composites having high mechanical elongation useful as a heat conducting portion of an electronic device | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-06-15 | — | — | US | claimed |
| US-20060127686-A1 | Thermally conductive polyimide film composites having high thermal conductivity useful in an electronic device | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-06-15 | — | — | US | claimed |
| US-20060110678-A1 | Low-temperature curable photosensitive compositions | DUPONT ELECTRONICS, INC. | 2006-05-25 | — | — | US | claimed |
| US-20060110679-A1 | Low-temperature curable photosensitive compositions | DUPONT ELECTRONICS, INC. | 2006-05-25 | — | — | US | claimed |
| EP-1659449-A2 | Low-temperature curable photosensitive compositions | E.I.Du pont de nemours and company (US) | 2006-05-24 | — | — | EP | claimed |
| EP-0698052-B1 | NEGATIVE BIREFRINGENT POLYIMIDE FILMS | UNIV AKRON (US) | 2000-06-14 | — | — | EP | claimed |
| JP-H08511812-A | — | — | 1996-12-10 | — | — | JP | claimed |
| WO-1994024191-A1 | NEGATIVE BIREFRINGENT POLYIMIDE FILMS | THE UNIVERSITY OF AKRON (US) | 1994-10-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070022-A1 | DESALINATION SYSTEM WITH POLYIMIDE MEMBRANE | TMED9, TMED2, SLC6A6 | MAOA 1675/4885MAOB 1813/4885TDP1 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.